Status | Study |
Recruiting |
Study Name: A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma Condition: Alveolar Soft Part Sarcoma Date: 2017-05-03 Interventions: Drug: Atezolizumab Atezolizumab is a human monoclonal antibody directed against programmed death-ligand |
Not yet recruiting |
Study Name: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma Condition: Alveolar Soft Part Sarcoma Leiomyosarcoma Date: 2017-01-06 Interventions: Drug: AL 3818 Other Name: Anlo |
Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition: Adrenal Cortex Carcinoma Adult Alveolar Soft Part Sarcoma Date: 2016-08-15 Interventions: Drug: Cabozantinib S-malate Gi |
Recruiting |
Study Name: Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Condition: Alveolar Soft Part Sarcoma Soft Tissue Sarcomas Date: 2015-12-14 Interventions: Drug: Axitinib Twice daily dos |
Recruiting |
Study Name: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Condition: Adult Fibrosarcoma Alveolar Soft Part Sarcoma Date: 2014-07-01 Interventions: Drug: Doxorubicin Hydrochloride |
Terminated |
Study Name: Pazopanib for Metastatic Alveolar Soft Part Sarcoma Condition: Metastatic Alveolar Soft Part Sarcoma Date: 2014-04-09 Interventions: Drug: Pazopanib Pazopanib 800mg qd daily for 4 weeks = 1 cycle |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-06-06 Interventions: Biological: cixutumumab Given |
Completed |
Study Name: Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas Condition: Childhood Alveolar Soft-part Sarcoma Childhood Angiosarcoma Date: 2012-03-27 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Date: 2012-02-06 Interventions: Drug: Gemcitabine Hydrochloride |
Recruiting |
Study Name: CREATE: Cross-tumoral Phase 2 With Crizotinib Condition: Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma Locally Advanced and/or Me Date: 2012-01-24 Interventions: Drug: Crizotinib (PF-02341066) For patients of 15yo and older, Capsules of 200 and 250 mg Daily dose of |